touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Stargardt disease: Improving awareness, diagnosis and patient support

    touchEXPERT FOCUS for touchOPHTHALMOLOGY

    Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews supportive care strategies to maximize patients’ functional vision and improve their wellbeing. 

    The expert:

    • Prof. Elias Traboulsi, Cleveland Clinic, Cleveland, OH, USA

      • This touchPODCAST is for HCPs in the USA only.

      This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc.

      The activity is jointly provided by USF Health and touchIME.

      For further information visit our website: www.touchOPHTHALMOLOGY.com

      38 min
    • Mastering DKA management: From pathophysiology to prevention and ketone monitoring strategies

      touchTALKS for touchENDOCRINOLOGY 


      Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and early intervention plus the advantages, drawbacks and recent developments in ketone monitoring.

      The experts

      • Prof. Jennifer Sherr, Yale School of Medicine, New Haven, CT, US

        • This touchPODCAST is for HCPs outside of the UK only.


        This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.
        This activity is jointly provided by USF Health and touchIME.

        touchIME is an EBAC® accredited provider. 


        For further information visit our website: 
        www.touchENDOCRINOLOGY.com

        29 min
      • A case-based discussion on PAH: Optimizing early detection, risk stratification and treatment decision-making

        touchCASES for touchRESPIRATORY and touchCARDIO

        This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment initiation and escalation.

        The experts:

        • Dr Athénaïs Boucly, University of Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
        • Prof. Pilar Escribano Subìas, Complutense University of Madrid, Spain

          • This touchPODCAST is for HCPs outside the UK

          This activity is provided by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME.

          touchIME is an EBAC® accredited provider

          For further information, visit our websites: www.touchRESPIRATORY.com and www.touchCARDIO.com

          38 min
        • Continuous glucose monitoring for cardiovascular risk reduction: The next frontier in preventive care

          touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY

          Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use.

          The experts:

          • Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA
          • Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA

            • This activity is for HCPs outside of the UK.

            This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc.

            This activity is jointly provided by USF Health and touchIME.

            touchIME is an EBAC® accredited provider.


            For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com

            29 min
          • HER2 as a targetable biomarker in gastrointestinal oncology

            touchEXPERT FOCUS for touchONCOLOGY

            Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches.

            The experts

            • Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA
            • Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium
            • Prof. Florian Lordick, University of Leipzig, Leipzig, Germany

              • This touchPODCAST is for HCPs outside of the UK

              This activity is funded by an independent medical education grant from AstraZeneca. 

              This activity is jointly provided by USF Health and touchIME. 

              touchIME is an EBAC® accredited provider. 

              For further information visit our website: 

              www.touchONCOLOGY.com 

              36 min
            • Navigating the evolving role of immunotherapy in advanced endometrial carcinoma

              touchPANEL DISCUSSION for touchONCOLOGY

              Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies.

              The experts

              • Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France
              • Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy
              • Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA

                • This touchPODCAST is for HCPs outside of the UK only.

                This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.


                This activity is jointly provided by USF Health and touchIME.
                touchIME is an EBAC® accredited provider.

                For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/ 

                44 min
              • Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease

                touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO

                Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes.

                The expert:

                • Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA

                  • This touchPODCAST is for HCPs in the USA only.

                  This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.

                  For further information visit our websites: 

                  https://touchneurology.com/ and https://touchcardio.com/

                  20 min
                • Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025

                  touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY

                  Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice.

                  Overview

                  • Data reviews with Prof. Moreau
                  • Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below

                    • Clinical themes

                    • Approved BCMA-directed therapeutic approaches 
                    • Practical application of BCMA-directed therapies
                    • Future of treating RRMM: Emerging BCMA-directed therapies and combinations

                      • The internationally renowned multiple myeloma expert faculty

                      • Prof. Philippe Moreau: Nantes, France
                        • Prof. Hermann Einsele: Würzburg, Germany
                          • Dr Paola Neri: Calgary, AB, Canada

                            • This touchPODCAST is for HCPs outside of the USA. 

                            This activity is funded by an independent medical education grant from GSK.

                            This activity is provided by touchIME.

                            touchIME is an EBAC® accredited provider.

                            For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com

                            1 hr 10 min
                          • Advancing care for patients with infantile haemangiomas: Timing is key

                            touchEXPERT FOCUS for touchDERMATOLOGY


                            Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey. 

                            The expert:

                            • Prof. Ilona Frieden, University of California, San Francisco, CA, USA

                              • This touchPODCAST is for HCPs outside of the UK only.

                              This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc.


                              This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA).

                              For further information visit our website:

                              https://touchdermaime.org/

                              18 min
                            • Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist

                              touchIN CONVERSATION for touchONCOLOGY

                              Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.

                              The experts

                              • Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
                              • Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA

                                • This touchPODCAST is for HCPs outside of the UK. 

                                This activity is funded by an independent medical education grant from Gilead Sciences, Inc.

                                The activity is jointly provided by USF Health and touchIME.

                                touchIME is an EBAC® accredited provider.


                                For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/

                                 

                                36 min

                              About touchPODCAST

                              From the publisher's feed

                              Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.